Photo coming soon
Tirzepatide
Shipping and payment
Chemistry & specifications
Reference data from public databases. For research use only.
| CAS Number | 2023788-19-2 |
|---|---|
| Molecular Formula | C225H348N48O68 |
| Molecular Weight | 4813 g/mol |
| Residue Count | 39 |
| Sequence (1-letter) | YXEGTFTSDYSIXLDKIAQKAFVQWLIAGGPSSGAPPPS |
| PubChem CID | 156588324 → |
Peer-reviewed research
Every research claim on this page traces to one of the 5 publications below.
- Tirzepatide for Obesity Treatment and Diabetes PreventionN Engl J Med (2025)View publication →
- Tirzepatide as Compared with Semaglutide for the Treatment of ObesityN Engl J Med (2025)View publication →
- Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trialLancet (2023)View publication →
- Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 DiabetesDiabetes Care (2023)View publication →
- Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysisDiabetologia (2022)View publication →